1 device · 1 company · 2026
Product code SIG: Transcranial Magnetic Stimulation System For Post Traumatic Stress Disorder (Ptsd)
1 device under product code SIG, 2026, from 1 company. Each record carries FDA's decision, the Indications for Use statement verbatim where the public document carries one (1 of 1 here), the regulation, and MAUDE report counts by product code.
Transcranial Magnetic Stimulation System For Post Traumatic Stress Disorder (Ptsd). 21 CFR 882.5802, Class II. External device that uses magnetic fields to induce neural activity in the cerebral cortex to treat neurological and psychiatric disorders and conditions. It is not intended for applying or focusing magnetic fields in brain areas outside cerebral cortex (e.g., cerebellum). MAUDE held 1 adverse-event report against this product code as of 2026-10-29; reports are unverified and the code is shared by every device of this type.
Retrieved from FDA public records.
Every device, newest decision first
| Decision | Device | Company | Panel | FDA |
|---|---|---|---|---|
| MeRT SystemK260402 · 510(k) | Wave Neuroscience | Neurology | database entry |
Every product code in the record, the whole record of FDA AI-enabled medical devices, or what Apodicta does on a medical record.